The validity of the acts edited by the National Health Surveillance Agency (Anvisa) in response to the covid-19 pandemic are being reviewed. As reported by the agency on Monday (18), these acts include resolutions dealing with the emergency use of vaccines and medicines.
Several acts published in an exceptional way by Anvisa, in response to the pandemic, initially provided for the end of its validity from the end of the State of Public Health Emergency of National Importance. This condition should have its end regulated this week through a new ordinance of the Ministry of Health.
“The request made by the Ministry of Health is that the validity of the Agency’s rules regarding the pandemic be maintained for one year from the moment of withdrawal from the state of Public Health Emergency of National Importance. The extension of the term of validity of the rules still depends on the approval of the Collegiate Board of Anvisa and, if approved, should allow vaccines and medicines in emergency use to continue in use for this period (one year)”, explained Anvisa.
In a note published today, the Agency highlights that vaccination against covid-19 must continue in progress and that the booster dose must be applied to the indicated audiences. For Anvisa, given the possibility of new variants, it is also necessary that epidemiological surveillance continues to act on the disease, through programs for testing and genomic mapping of the virus in circulation in Brazil.
“Each person must continue to pay attention to hand hygiene measures and the use of a mask in higher risk environments, with agglomerations”, highlighted the health surveillance body, remembering that, despite the advances made in Brazil, many countries are still in a state of emergency. pandemic and with still low vaccination rates, needing to immunize their populations.